Cetrelimab (JNJ 63723283) is a humanized anti-PD-1 monoclonal antibody that dose-dependently increases T cell-mediated cytokine production and stimulates cytokine expression. It is used in multiple myeloma and bladder cancer research.
Purity:
>95%
CAS Number:
[2050478-92-5]
Target:
Interleukin|||PD-1/PD-L1|||TNF
* VAT and and shipping costs not included. Errors and price changes excepted
